If Big Pharma was a boy’s club before, now it’s even more so.
GSK announced this week that CEO Emma Walmsley is stepping down and handing the reins to the company’s chief commercial officer Luke Miels by the end of the year.
The shift brings GSK into what Walmsley described as a…